Rifaximin reduces rehospitalization risk in patients with cirrhosis and overt hepatic encephalopathy
{{output}}
Background: Rifaximin treatment is associated with reduced rates of overt hepatic encephalopathy (OHE) hospitalization relative to lactulose alone. This real-world study evaluated the impact of treatment on rehospitalizations fol... ...
